Pediatrics

Your daily dose of clinical news you may have missed.

In a study of over 1000 children and adolescents, authors identified 4 distinct profiles of psychiatric comorbidity with differing risk for a self-harm event.

In gummy products with melatonin, the actual amount ranged from 74% to 347% of the labeled quantity, according to a new analysis.

Your daily dose of clinical news you may have missed.

Results from a prospective birth cohort study show an age-dependent association between RSV infection during infancy and childhood asthma.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Young tobacco smokers who also vape face an increased risk of persistent and heavier smoking later in adolescence, according to data from 2 large-scale cohorts in the UK and US.

Your daily dose of clinical news you may have missed.

Researchers found no association between maternal opioid prescription postpartum and several adverse infant outcomes, including rehospitalization and emergency department visits.

Your daily dose of clinical news you may have missed.

Pediatric hypertension and the need for appropriate diagnosis, treatment, and reduction of lifestyle risk factors outlined in new scientific statement.

The 5-in-1 vaccine candidate, if approved, would provide the broadest meningococcal serogroup coverage and simplify the vaccination schedule.

Each of the quotes is taken from a study reviewed on Patient Care during the week and was chosen for the research team’s passion about the implications of their findings.

Your daily dose of clinical news you may have missed.

Young children using a hybrid closed-loop insulin delivery system spent 12% more time within their target blood glucose range than those who received standard care, according to new research.

The FDA authorized Pfizer's bivalent vaccine as a booster dose for children aged under 5 years who received 3 doses of monovalent vaccine.

Youth at the upper range of normal weight had a 26% higher risk of developing hypertension than those in the lower range of normal weight, according to a new study.

The SGLT-2 inhibitor, if approved for this age group, would be the first agent in the class with the indication as adjunctive treatment for T2D for those younger than age 18.

About 60% of dual vapers experienced depression and 52% experienced anxiety, according to findings from a survey of over 2500 youth and young adults.

Substance use among teenagers decreased for some substances from 2011 to 2021, but there is still progress to be made, according to the latest CDC Youth Risk Behavior Survey.

Your daily dose of clinical news you may have missed.

Find key takeaways from the US Centers for Disease Control and Prevention's latest Youth Risk Behavior Survey in our new slideshow.

Future studies may consider PARS the new gold standard in predicting pediatric asthma risk, said study authors.

Pfizer will present pivotal phase 3 data for RSVpreF to the ACIP on February 23; FDA has set a PDUFA date for the vaccine candidate of August 2023.

Your daily dose of clinical news you may have missed.

Reductions in depressive symptoms were greater in adolescents aged ≥13 years and in those with a mental illness and/or depression diagnosis, according to systematic review and meta-analysis.

The novel oral agent is administered once daily for 14 days and has demonstrated rapid and sustained improvement in symptoms across trials.

Vaccination was associated with lower risks of infection, COVID-19-related illnesses, and hospitalizations due to COVID-19-related illnesses in children.

The COVID-19 pandemic derailed routine immunizations and triggered a flood of vaccine misinformation beyond the COVID shot. Here, 3 ways to move forward.